BMO Capital Downgrades Terns Pharmaceuticals (TERN) to Market Perform

March 26, 2026 4:06 PM

BMO Capital analyst Evan David Seigerman downgraded Terns Pharmaceuticals (NASDAQ: TERN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found